Douglas Sawyer Archives

March 14, 2013

Heart failure therapy shows promise in early clinical trial

Vanderbilt University Medical Center and Acorda Therapeutics Inc. released findings from a Phase 1 clinical trial of glial growth factor 2 (GGF2) last week at the American College of Cardiology Annual Scientific Session in San Francisco.

By Kathy Whitney

August 2, 2012

VHVI reaches milestone in heart valve procedures

Vanderbilt Heart and Vascular Institute recently performed its 100th transcatheter aortic heart valve-replacement (TAVR) on 91-year-old Murline Westover from Lavinia, Tenn.